Cited by

• 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.

  Geishofer G, Binder A, Müller M, Zöhrer B, Resch B, Müller W, Faber J, Finn A, Endler G, Mannhalter C, Zenz W; Central European Meningococcal Genetic Study Group. Geishofer G, et al. Eur J Pediatr. 2005 Aug;164(8):486-90. doi: 10.1007/s00431-005-1673-4. Epub 2005 Apr 21. Eur J Pediatr. 2005. PMID: 15843979
• Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

  Bendapudi PK, Robbins A, LeBoeuf N, Pozdnyakova O, Bhatt A, Duke F, Sells R, McQuiston J, Humrighouse B, Rouaisnel B, Colling M, Stephenson KE, Saavedra A, Losman JA. Bendapudi PK, et al. Blood Adv. 2018 Nov 13;2(21):2917-2921. doi: 10.1182/bloodadvances.2018024430. Blood Adv. 2018. PMID: 30396911 Free PMC article. No abstract available.
• A newborn with grouped facial skin lesions and subsequent seizures.

  Döring M, Rohrer KM, Tsiflikas I, Buchenau W, Wilke M, Handgretinger R, Poets CF, Goelz R. Döring M, et al. BMC Pediatr. 2014 May 22;14:126. doi: 10.1186/1471-2431-14-126. BMC Pediatr. 2014. PMID: 24884686 Free PMC article.
• Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia.

  Binder A, Endler G, Rieger S, Geishofer G, Resch B, Mannhalter C, Zenz W; Central European Meningococcal Genetic Study Group. Binder A, et al. Hum Genet. 2007 Sep;122(2):183-90. doi: 10.1007/s00439-007-0392-5. Epub 2007 Jun 14. Hum Genet. 2007. PMID: 17569089
• Empiric treatment of protracted idiopathic purpura fulminans in an infant: a case report and review of the literature.

  Macheret F, Pundi KN, Broomall EM, Davis DM, Rodriguez V, Brands CK. Macheret F, et al. J Med Case Rep. 2011 May 23;5:201. doi: 10.1186/1752-1947-5-201. J Med Case Rep. 2011. PMID: 21605440 Free PMC article.